A vs SGMO · P/E 29, rev $1.88B vs rev $57.8M
Agilent Technologies Inc (A) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
A currently screens at market cap $33.70B and trailing P/E 29.2. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the A and SGMO stock pages for the full models.
Not investment advice.